Protalix BioTherapeutics to Release Third Quarter 2021 Financial Results and Provide a Financial and Business Update on November 15, 2021
- Monday, November 8, 2021, 7:11
- PR Newswire
- Add a comment
CARMIEL, Israel, Nov. 8, 2021 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…
About the Author
admin has written 20652 stories on this site.